top of page

Silverleaf Medical Sciences Story

Silverleaf develops solutions to power next-generation heart failure management systems. The value that Silverleaf delivers to this market is the ability to dramatically improve the accuracy, sensitivity, and robustness of heart failure management for the purpose of reducing hospital admission and improve the quality of life for HF patients. Silverleaf’s technology enables the development of devices that will have extensive accessibility to patients and that will meet the demand for effectiveness of heart failure management. It is committed to providing software solutions for effective heart failure management that benefits 64.3 millions of heart failure patients worldwide.

Meet The Team

画板 2.png

Vincint Zhang

Founders & Chairman

画板 4.png

Islam Abudayyeh

Chief Medical Consoultant

画板 1.png

Arnold Zheng

Chief Data Scientist

  • A Zheng
  • 領英

    Updates and News

    Jan 25, 2023

    We are proud to announce the additions of Dr. Leon Sun, Dr. Yichen Cao, Mr. Todd Eis and Dr. Cyril Rakovski to our leadership team. They will add significantly to our teams expertise as we gear up to the next phase of our clinical studies and product development.

    Silverleaf News

    Sep 20, 2022

    Silverleaf is in the process of finalizing the research agreement and IRB with the Loma Linda Vetrans Administration hospital, and exploring collaboration with additional academic healthcare facilities.

    Clinical Study

    Mar 1, 2022

    We are pleased that we have enrolled our first patient into the ADOPTS trial in partnership with PIH-Good Samaritan Hospital ​in Los Angeles.

    Clinical Study

    Our Partners

    VA.jpg
    GoodSAM.jpg
    Chapman_University_logo.gif
    bottom of page